373 related articles for article (PubMed ID: 22704268)
1. Molecular marks for epigenetic identification of developmental and cancer stem cells.
Patra SK; Deb M; Patra A
Clin Epigenetics; 2011 Apr; 2(1):27-53. PubMed ID: 22704268
[TBL] [Abstract][Full Text] [Related]
2. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
[TBL] [Abstract][Full Text] [Related]
3. Cell-type dependent regulation of pluripotency and chromatin remodeling genes by hydralazine.
Aguirre-Vázquez A; Castorena-Torres F; Silva-Ramírez B; Peñuelas-Urquides K; Camacho-Moll ME; Salazar-Olivo LA; Velasco I; Bermúdez de León M
Stem Cell Res Ther; 2023 Mar; 14(1):42. PubMed ID: 36927767
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
Niharika ; Roy A; Mishra J; Chakraborty S; Singh SP; Patra SK
Prog Mol Biol Transl Sci; 2023; 197():241-260. PubMed ID: 37019595
[TBL] [Abstract][Full Text] [Related]
5. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
6. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines.
Wang XQ; Ng RK; Ming X; Zhang W; Chen L; Chu AC; Pang R; Lo CM; Tsao SW; Liu X; Poon RT; Fan ST
PLoS One; 2013; 8(9):e72435. PubMed ID: 24023739
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.
Maali A; Maroufi F; Sadeghi F; Atashi A; Kouchaki R; Moghadami M; Azad M
Epigenomics; 2021 Apr; 13(8):631-647. PubMed ID: 33823614
[TBL] [Abstract][Full Text] [Related]
9. OCT4, SOX2 and NANOG co-regulate glycolysis and participate in somatic induced reprogramming.
Ding Y; Yuan X; Zou Y; Gao J; Xu X; Sun H; Zuo Q; Zhang Y; Li B
Cytotechnology; 2022 Jun; 74(3):371-383. PubMed ID: 35733702
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.
Yang J; Chai L; Fowles TC; Alipio Z; Xu D; Fink LM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19756-61. PubMed ID: 19060217
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
13. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
14. Exogenous LIN28 Is Required for the Maintenance of Self-Renewal and Pluripotency in Presumptive Porcine-Induced Pluripotent Stem Cells.
Chakritbudsabong W; Chaiwattanarungruengpaisan S; Sariya L; Pamonsupornvichit S; Ferreira JN; Sukho P; Gronsang D; Tharasanit T; Dinnyes A; Rungarunlert S
Front Cell Dev Biol; 2021; 9():709286. PubMed ID: 34354993
[TBL] [Abstract][Full Text] [Related]
15. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
Miyamoto T; Furusawa C; Kaneko K
PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
[TBL] [Abstract][Full Text] [Related]
16. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
17. Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes.
Santourlidis S; Wernet P; Ghanjati F; Graffmann N; Springer J; Kriegs C; Zhao X; Brands J; Araúzo-Bravo MJ; Neves R; Koegler G; Uhrberg M
Stem Cell Res; 2011 Jan; 6(1):60-9. PubMed ID: 20933485
[TBL] [Abstract][Full Text] [Related]
18. Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network.
Du Z; Wen X; Wang Y; Jia L; Zhang S; Liu Y; Zhou L; Li H; Yang W; Wang C; Chen J; Hao Y; Salgado Figueroa D; Chen H; Li D; Chen N; Celik I; Zhu Y; Yan Z; Fu C; Liu S; Jiao B; Wang Z; Zhang H; Gülsoy G; Luo J; Qin B; Gao S; Kapranov P; Esteban MA; Zhang S; Li W; Ay F; Chen R; Hoffman AR; Cui J; Hu JF
Genome Biol; 2021 Aug; 22(1):233. PubMed ID: 34412677
[TBL] [Abstract][Full Text] [Related]
19. Going up the hill: chromatin-based barriers to epigenetic reprogramming.
Arabacı DH; Terzioğlu G; Bayırbaşı B; Önder TT
FEBS J; 2021 Aug; 288(16):4798-4811. PubMed ID: 33190371
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors.
Amaya CN; Bryan BA
BMC Clin Pathol; 2015; 15():18. PubMed ID: 26412983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
